Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2003
05/29/2003US20030100027 Methods and compositions using coiled binding partners
05/29/2003US20030100026 Stimulus-inducible protein kinase complex and methods of use therefor
05/29/2003US20030100025 Detection of inhibitors of ecdysteroid biosynthesis; obtain ecdysteroid biosynthetic enzyme, incubate with modulator, monitor adjustment in enzyme activity, reduction in enzyme activity indicates inhibitor of ecdysteriod biosynthesis
05/29/2003US20030100024 Detection of morphological adjustments in cell; obtain cells, deposit on solid support, label cell structures, scan cells, detect signal, evaluate cells for morphological adjustments
05/29/2003US20030100021 Genetically engineered receptor for use in the detection and analysis of protein binding activity
05/29/2003US20030100020 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
05/29/2003US20030100019 Supported membrane, preparation and uses
05/29/2003US20030100016 Complement C3 precursor biopolymer markers predictive of Alzheimers disease
05/29/2003US20030100015 Protein biopolymer markers indicative of age matched control
05/29/2003US20030100014 Apolipoprotein biopolymer markers predictive of type II diabetes
05/29/2003US20030100013 HP biopolymer markers predictive of insulin resistance
05/29/2003US20030100012 Plasma protease C1 biopolymer markers predictive of alzheimers disease
05/29/2003US20030100011 IG lambda biopolymer markers predictive of alzheimers disease
05/29/2003US20030100010 Fibrinogen biopolymer Marker predictive of type II diabetes
05/29/2003US20030100009 Inter alpha trypsin inhibitor biopolymer markers indicative of insulin resistance
05/29/2003US20030100007 Detection of preferential binding agents; form peptide library, incubate target, recover peptide which bind to target, expose target to non-peptide binding agent, recover bound target, determine structure of nonpeptide binding agent
05/29/2003US20030100005 CRBs as modifiers of branching morphogenesis and methods of use
05/29/2003US20030100000 Isolation of codon associated with preferential peptides; obtain peptide sample, incubate with degrading agent, recover products, expose to substrate, incubate with solid support, remove substrate, release codon from support
05/29/2003US20030099999 Assay procedure using fluorogenic tracers
05/29/2003US20030099998 Development of method for screening physiologically active pyrrole imidazole derivative
05/29/2003US20030099991 Detection of nucleotide sequences associated pain and nervous system disorders; obtain sample, incubate with probe, detect signal, recover nucleic acid, incubate with primer, amplify, evaluate for disorder
05/29/2003US20030099989 Fluorescent probes for chromosome painting
05/29/2003US20030099988 Novel Human tumor suppressor
05/29/2003US20030099979 Diagnosing asthmatic response; obtain tissue sample, extract nnucleotide sequences, incubate with probe for marker gene, measure gene expression, evaluate for asthma response
05/29/2003US20030099974 Novel genes, compositions, kits and methods for identification, assessment, prevention, and therapy of breast cancer
05/29/2003US20030099971 Epidermal differentiation factor
05/29/2003US20030099970 Human-derived bradeion proteins, DNA coding for the proteins, and uses thereof
05/29/2003US20030099968 Semiconductor nanocrystal probes for biological applications and process for making and using such probes
05/29/2003US20030099964 Methods for genomic analysis
05/29/2003US20030099963 Nucleotied sequences coding polypeptide for use in the diagnosis and treatment of cancer
05/29/2003US20030099958 Detection of vascular system disorders; obtain nucleotide sequence sample, sequence, detect polymorphisms, evaluate for vascular system disorders
05/29/2003US20030099955 Detection of enzyme modulators; obtain three dimensional structure of enzyme, design modulator to bind active site, incubate with test modulator, monitor adjustment in enzyme activity
05/29/2003US20030099949 Generation of solid support for use in the analysis of preferential particles; prepare slurry, deposit on substrate and microparticles, immobilze particles and form matrix, recover solid sopport
05/29/2003US20030099946 Detection of fungal pathogens using the polymerase chain reaction
05/29/2003US20030099944 Combination therapy involving drugs which target cellular proteins and drugs which target pathogen-encoded proteins
05/29/2003US20030099940 Single target counting assays using semiconductor nanocrystals
05/29/2003US20030099933 Monitoring toxicity of drug treatment in humans; obtain blood sample, determine mitochondrial concentration, compare to control, adjustment in concentration indicates drug toxicity
05/29/2003US20030099930 Generation of preferential microarrays; obtain dendrimeric polyamine, generate solid support, recover solid support
05/29/2003US20030099929 Saliva immunoassay for detection of exposure to infectious agents
05/29/2003US20030099927 Arrays for bringing two or more reagents in contact with one or more biological targets and methods for making and using the arrays
05/29/2003US20030099926 Response element compositions and assays employing same
05/29/2003US20030099773 Solution striping system
05/29/2003US20030099763 Shaped microcomponent via reactive conversion of biologically-derived microtemplates
05/29/2003US20030099682 Tissue/implant interface comprising implant and bioactive polymer layer adjacent surface of implant, wherein polymer layer contains tissue response modifier covalently attached to polymer layer
05/29/2003US20030099662 Proteins
05/29/2003US20030099661 Compositions and methods for the treatment of immune related diseases
05/29/2003US20030099660 For regenerating tissues; antiaging agents; medical diagnosis; monitoring chemotherapy
05/29/2003US20030099656 Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections
05/29/2003US20030099654 Comprises antibodies/proteins providing inhibition of prothrombinase; treatment and prevention of bacterial and viral infections, allograft/xenograft rejection, glomerulo-nephritis, cancer, gastrointestinal diseases, and fetal loss
05/29/2003US20030099646 For interfering with cyclin expression or phosphorylation via map-kinase; hybridomas; antitumor agents; antiproliferative agents
05/29/2003US20030099645 Treating human diseases by administering said immunoglobulin (IgM) having specificity to extracellular receptors on lymphocytes; prevents HIV infection, treating cancer; IgM developed at birth in absence of deliberate immunization
05/29/2003US20030099642 Inhibiting activation by CD40 ligand (CD40L) of cells bearing CD40 on the cell surface, other than B cells, by contacting with an agent that inhibits the interaction between CD40L and the cells; treating autoimmune diseases, for example
05/29/2003US20030099641 Does not bind to esterogen receptor (ER) alpha when not phosphorylated at Serine 118; use in drug screening, diagnosis, detection for breast cancer
05/29/2003US20030099627 Method for determining modulation of p110delta activity
05/29/2003US20030099625 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/29/2003US20030099611 Manipulation and detection of protein phosphatase 2c-pp2calpha - expression in tumor cells for cancer therapy, prevention and detection
05/29/2003US20030099609 Canine IL-4 nucleic acid molecules and uses thereof
05/29/2003US20030099608 Human cytokine receptor
05/29/2003US20030099607 Ifn-y production inducing protein (igif, il-18)
05/29/2003US20030099580 Universal microscope slide cassette
05/29/2003US20030099579 Efficiently analysis of protein samples by preventing them being denatured/deactivated due to drying; having moveable opening/closing coverings supported on a resilient holder; microliter/nanoliter per spot; blood; oligonucleotides
05/29/2003US20030099575 Dissolving soluble tungsten compound in a solvent, adding thickener to the solution to adjust the viscosity, coating on the substrate, sintering; adding a sintered catalyst layer; stability; sensitivity; catalyst selectivity
05/29/2003US20030099574 Fluorescence based oxygen sensor systems
05/29/2003US20030099383 Method of enabling an analysis of an external body portion
05/29/2003US20030099193 Multiport non-blocking high capacity ATM and packet switch
05/29/2003US20030098976 Measuring method for immunochromatographic test strip
05/29/2003US20030098969 Spectroscopic fluid analyzer
05/29/2003US20030098796 System and technique for detecting the presence of foreign material
05/29/2003US20030098772 Carbon monoxide detector
05/29/2003US20030098771 Robust fluid and property microsensor assembly made of optimal material
05/29/2003US20030098697 Apparatus and method for non-destructive inspection
05/29/2003US20030098437 In situ prepared nanocolloids treated with strong reductants in solvent and precious metal salts added to mixtures
05/29/2003US20030098409 Systems and techniques for detecting the presence of foreign material
05/29/2003US20030098271 Comprises species-immobilizing filter within tubular housing; for polymerase chain reaction (PCR)
05/29/2003US20030098248 Multiaperture sample positioning and analysis system
05/29/2003US20030098242 Fixing biomolecules to blocked polypyrroles, polythiophenes, and polyanilines; for production of DNA chips
05/29/2003US20030098235 For electrophoretic or chromatographic analysis; uniform coupling without overstaining
05/29/2003US20030098234 Biosensor
05/29/2003US20030098233 Determination of sample volume adequacy in biosensor devices
05/29/2003US20030097981 Solution striping system
05/29/2003US20030097889 Vapor trap system and associated method for detecting volatile organic chemical vapors
05/29/2003US20030097824 Specimen vial sealing apparatus and method
05/28/2003EP1315099A1 Microbe analyzing system and method, and database
05/28/2003EP1314984A2 Highly concentrated Creatininsolutions for use in renal function test
05/28/2003EP1314983A1 Bioanalytical measuring method for catalases and peroxidases, their conjugates, substrates, activators and inhibitors
05/28/2003EP1314982A1 Highly reproducible agglutination immunoassay method and reagents
05/28/2003EP1314981A2 Benzo[c,d]indole-fluorochromes for labelling biomolecules and polymer particles
05/28/2003EP1314980A2 A system for cell-based screening
05/28/2003EP1314979A1 Method and device for determining state of skin surface
05/28/2003EP1314978A1 Biosensor
05/28/2003EP1314977A1 Method of detecting gas with the use of photocurrent amplification and the like and gas sensor
05/28/2003EP1314787A2 The Midkine gene is associated with cancer
05/28/2003EP1314786A1 Method of examining diseases with inborn errors of metabolism and examination apparatus therefor
05/28/2003EP1314784A1 G-protein coupled receptor LUSTR2 and uses thereof
05/28/2003EP1314431A2 Newcastle disease virus for therapeutic use
05/28/2003EP1314429A2 Use of an antiretroviral compound to manufacture a medicament for the treatment of sjogren's syndrome, systematic lupus erythematosis, scleroderma, or juvenile rheumatoid arthritis
05/28/2003EP1314395A2 Method for multi-site skin testing
05/28/2003EP1314189A2 Doped elongated semiconductors, their growth and applications
05/28/2003EP1314124A2 Methods of dna marker-based genetic analysis using estimated haplotype frequencies and uses thereof
05/28/2003EP1314079A2 A METHOD FOR i AB INITIO /i DETERMINATION OF MACROMOLECULAR CRYSTALLOGRAPHIC PHASES AT MODERATE RESOLUTION BY A SYMMETRY-ENFORCED ORTHOGONAL MULTICENTER SPHERICAL HARMONIC-SPHERICAL BESSEL EXPANSION
1 ... 2581 2582 2583 2584 2585 2586 2587 2588 2589 2590 2591 2592 2593 2594 2595 2596 2597 2598 2599 2600 2601 ... 3937